Is there any relationship between adverse pregnancy outcome and first trimester nuchal translucency measurements in normal karyotype fetuses?

Basit Öğe Kaydı
dc.contributor.authorUysal, Fatma
dc.contributor.authorCosar, Emine
dc.contributor.authorYucesoy, Kaya
dc.contributor.authorGencer, Meryem
dc.contributor.authorCevizci, Sibel
dc.contributor.authorGungor, Aysenur
dc.contributor.authorHacivelioglu, Servet
dc.date.accessioned2025-01-27T20:29:18Z
dc.date.available2025-01-27T20:29:18Z
dc.date.issued2015
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractAim: This study aims to research whether there is a relationship between first trimester nuchal translucency (NT) measurements and pregnancy complications such as gestational diabetes mellitus (GDM), gestational hypertension (GHT), intrauterine growth restriction (IUGR) and oligohydramnios. Method: This study included 225 singleton pregnancies attending Canakkale Onsekiz Mart University Obstetrics and Gynecology clinic for all monitoring and examinations, and gave birth at our clinic between January 2011 and December 2012. Data sources were clinical records and the hospital's automation system, and the study was planned as retrospective cohort. NT measurement was made between 10 weeks 3 days and 13 weeks 6 days gestation. For data analysis, the chi-square, Mann-Whitney U test and Spearman correlation were used. Results: Of pregnancies, in the study, 5 (2.2%) developed GDM, 6 (2.6%) developed GHT, 2 (0.89%) developed IUGR and 10 (4.4%) developed oligohydramnios. There was no correlation identified between NT measurements and development of GDM, GHT, IUGR and oligohydramnios. Conclusion: There was no relationship found between first trimester NT measurements and complications that could develop in pregnancy. For the first time in the literature, NT and oligohydramnios were studied and no relationship was observed.
dc.identifier.doi10.3109/14767058.2014.923396
dc.identifier.endpage534
dc.identifier.issn1476-7058
dc.identifier.issn1476-4954
dc.identifier.issue5
dc.identifier.pmid24824104
dc.identifier.scopus2-s2.0-84929309175
dc.identifier.scopusqualityQ1
dc.identifier.startpage531
dc.identifier.urihttps://doi.org/10.3109/14767058.2014.923396
dc.identifier.urihttps://hdl.handle.net/20.500.12428/22902
dc.identifier.volume28
dc.identifier.wosWOS:000354475700009
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherInforma Healthcare
dc.relation.ispartofJournal of Maternal-Fetal & Neonatal Medicine
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectAdverse pregnancy outcome
dc.subjectgestational diabetes
dc.subjectgestational hypertension
dc.subjectIUGR
dc.subjectnuchal translucency
dc.subjectoligohydramnios
dc.titleIs there any relationship between adverse pregnancy outcome and first trimester nuchal translucency measurements in normal karyotype fetuses?
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu